$FBLG
FibroBiologics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Houston, TX
FBLG chart
What traders are saying about $FBLG
Latest postsFibroBiologics, Inc. news
- Fibrobiologics Inc expected to post a loss of 63 cents a share - Earnings Preview
TradingView ·
- FibroBiologics, Inc. Estimates – NASDAQ:FBLG
TradingView ·
- What Is Powering the Rally in Karyopharm Therapeutics, Estrella Immunopharma, CytoSorbents, MoonLake Immunotherapeutics, FibroBiologics, Exicure, Biohaven and Profusa Stocks Today, and What Should Investors Know About the Catalysts?
kalkine.ca ·
- FibroBiologics Presents Preclinical Data on Fibroblast Spheroid-Derived Chondrocyte Spheroids for Degenerative Disc Disease at the North American Spine Society 2026 Annual Meeting
Yahoo Finance ·
- FibroBiologics Announces Australian Patent Accepted for Cellular Blend for the Regeneration of Chondrocytes and Cartilage Cells in Degenerated Spinal Discs
Yahoo Finance ·
- FibroBiologics Files Patent Application for Technology Designed to Produce GLP-1 and Other Therapeutic Peptides Inside the Body
Yahoo Finance ·
- EXCLUSIVE: FibroBiologics Files Patent Application For Cell-Based Alternative to GLP-1 Injections
Yahoo Finance ·
- FibroBiologics Announces Grant of European Patent for Methods of Enhancing Fibroblast Therapeutic Activity
Yahoo Finance ·
- Nova Minerals and FibroBiologics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
Yahoo Finance ·
- FibroBiologics Announces Closing of $0.5 Million Private Placement with Chief Scientific Officer
Yahoo Finance ·
- Join FibroBiologics' Live Investor Webinar: Advancing a Fibroblast-Based Cell Therapy Platform Across Multiple High-Value Indications
Yahoo Finance ·
- FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing
Yahoo Finance ·
FibroBiologics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$18.6M | -$11.2M | -$16.5M | -$5.1M |
| Diluted EPS | $-0.42 | $-0.34 | $-0.68 | $-0.18 |
| Total assets (year end) | $9.6M | $16.4M | $11.8M | $4.8M |
| Cash and equivalents (year end) | $4.9M | $14.0M | $9.2M | $2.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About FibroBiologics, Inc.
- Ticker
- FBLG (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Houston, TX
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1958777
- Former names
- FibroBiologics Inc.
Frequently asked questions
What exchange is FibroBiologics, Inc. listed on?
FibroBiologics, Inc. trades on the Nasdaq under the ticker symbol FBLG.
What industry is FibroBiologics, Inc. in?
FibroBiologics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is FibroBiologics, Inc. headquartered?
FibroBiologics, Inc.'s business address on file with the SEC is in Houston, TX.
When does FibroBiologics, Inc.'s fiscal year end?
FibroBiologics, Inc.'s fiscal year ends on December 31.